• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硫代珊瑚素通过PI3K/Akt/BCRP信号通路介导MCF-7细胞的耐药性。

Thiocoraline mediates drug resistance in MCF-7 cells via PI3K/Akt/BCRP signaling pathway.

作者信息

Jin Jin, Zhao Yujia, Guo Wan, Wang Bingrong, Wang Yigang, Liu Xinyuan, Xu Chuanlian

机构信息

College of Life Sciences, Zhejiang Sci-Tech University, Xiasha Higher Education Zone, Hangzhou, 310018, Zhejiang Province, China.

Xinyuan Institute of Medicine and Biotechnology, College of Life Sciences, Zhejiang Sci-Tech University, No. 2 Road Xiasha District, Hangzhou, 310018, China.

出版信息

Cytotechnology. 2019 Feb;71(1):401-409. doi: 10.1007/s10616-019-00301-w. Epub 2019 Jan 28.

DOI:10.1007/s10616-019-00301-w
PMID:30689149
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6368516/
Abstract

Thiocoraline, a depsipeptide bisintercalator with potent antitumor activity, was first isolated from marine actinomycete Micromonospora marina. It possesses an intense toxicity to MCF-7 cells at nanomolar concentrations in a dose-dependent manner evaluated by MTT assay and crystal violet staining. We established a human breast thiocoraline-resistant cancer subline of MCF-7/thiocoraline (MCF-7/T) to investigate the expression variation of breast cancer resistance proteins (BCRP) and its subsequent influence on drug resistance. Colony-forming assay showed that the MCF-7 cells proliferated faster than the MCF-7/T cells in vitro. Western blot analysis demonstrated that thiocoraline increased the phosphorylation of Akt. Additionally, the sensitivity of tumor cells to thiocoraline was reduced with a concurrent rise in phosphorylation level of Akt and of BCRP expression.These studies indicated that thiocoraline probably mediated the drug resistance via PI3K/Akt/BCRP signaling pathway. MK-2206 dihydrochloride, a selective phosphorylation inhibitor of Akt, significantly decreased MCF-7 cell viability under exposure to thiocoraline compared to the control. However, it was not obviously able to decrease MCF-7/T cell viability when cells were exposed to thiocoraline.

摘要

硫代珊瑚素是一种具有强大抗肿瘤活性的缩肽双嵌入剂,最初从海洋放线菌滨海小单孢菌中分离得到。通过MTT法和结晶紫染色评估,它在纳摩尔浓度下对MCF-7细胞具有强烈的毒性,且呈剂量依赖性。我们建立了人乳腺癌硫代珊瑚素耐药细胞亚系MCF-7/硫代珊瑚素(MCF-7/T),以研究乳腺癌耐药蛋白(BCRP)的表达变化及其对耐药性的后续影响。集落形成试验表明,MCF-7细胞在体外比MCF-7/T细胞增殖更快。蛋白质免疫印迹分析表明,硫代珊瑚素增加了Akt的磷酸化。此外,随着Akt磷酸化水平和BCRP表达的同时升高,肿瘤细胞对硫代珊瑚素的敏感性降低。这些研究表明,硫代珊瑚素可能通过PI3K/Akt/BCRP信号通路介导耐药性。Akt的选择性磷酸化抑制剂盐酸MK-2206,与对照组相比,在硫代珊瑚素作用下显著降低了MCF-7细胞的活力。然而,当细胞暴露于硫代珊瑚素时,它并不能明显降低MCF-7/T细胞的活力。

相似文献

1
Thiocoraline mediates drug resistance in MCF-7 cells via PI3K/Akt/BCRP signaling pathway.硫代珊瑚素通过PI3K/Akt/BCRP信号通路介导MCF-7细胞的耐药性。
Cytotechnology. 2019 Feb;71(1):401-409. doi: 10.1007/s10616-019-00301-w. Epub 2019 Jan 28.
2
Guajadial reverses multidrug resistance by inhibiting ABC transporter expression and suppressing the PI3K/Akt pathway in drug-resistant breast cancer cells.瓜笄甙通过抑制 ABC 转运蛋白的表达和抑制耐药乳腺癌细胞中的 PI3K/Akt 通路逆转多药耐药性。
Chem Biol Interact. 2019 May 25;305:98-104. doi: 10.1016/j.cbi.2019.03.032. Epub 2019 Mar 28.
3
[Regulation mechanism of breast cancer resistance protein by toremifene to reverse BCRP-mediated multidrug resistance in breast cancer cells].[托瑞米芬对乳腺癌耐药蛋白的调控机制以逆转乳腺癌细胞中BCRP介导的多药耐药性]
Zhonghua Zhong Liu Za Zhi. 2011 Sep;33(9):654-60.
4
Up-regulation of breast cancer resistance protein plays a role in HER2-mediated chemoresistance through PI3K/Akt and nuclear factor-kappa B signaling pathways in MCF7 breast cancer cells.上调乳腺癌耐药蛋白通过 MCF7 乳腺癌细胞中的 PI3K/Akt 和核因子-κB 信号通路在 HER2 介导的化疗耐药中发挥作用。
Acta Biochim Biophys Sin (Shanghai). 2011 Aug;43(8):647-53. doi: 10.1093/abbs/gmr050. Epub 2011 Jun 28.
5
The PI3K/Akt inhibitor LY294002 reverses BCRP-mediated drug resistance without affecting BCRP translocation.PI3K/Akt 抑制剂 LY294002 逆转 BCRP 介导的耐药性而不影响 BCRP 易位。
Oncol Rep. 2012 Jun;27(6):1703-9. doi: 10.3892/or.2012.1724. Epub 2012 Mar 15.
6
Effects of endoplasmic reticulum stress on the autophagy, apoptosis, and chemotherapy resistance of human breast cancer cells by regulating the PI3K/AKT/mTOR signaling pathway.内质网应激通过调控PI3K/AKT/mTOR信号通路对人乳腺癌细胞自噬、凋亡及化疗耐药性的影响
Tumour Biol. 2017 May;39(5):1010428317697562. doi: 10.1177/1010428317697562.
7
Regulation of AKT phosphorylation by GSK3β and PTEN to control chemoresistance in breast cancer.通过 GSK3β 和 PTEN 调节 AKT 磷酸化以控制乳腺癌的化疗耐药性。
Breast Cancer Res Treat. 2019 Jul;176(2):291-301. doi: 10.1007/s10549-019-05239-3. Epub 2019 Apr 20.
8
Paclitaxel resistance in MCF-7/PTX cells is reversed by paeonol through suppression of the SET/phosphatidylinositol 3-kinase/Akt pathway.丹皮酚通过抑制SET/磷脂酰肌醇3激酶/Akt信号通路逆转MCF-7/PTX细胞的紫杉醇耐药性。
Mol Med Rep. 2015 Jul;12(1):1506-14. doi: 10.3892/mmr.2015.3468. Epub 2015 Mar 11.
9
miR-302a/b/c/d cooperatively inhibit BCRP expression to increase drug sensitivity in breast cancer cells.微小RNA-302a/b/c/d协同抑制乳腺癌耐药蛋白(BCRP)的表达,以提高乳腺癌细胞对药物的敏感性。
Gynecol Oncol. 2016 Jun;141(3):592-601. doi: 10.1016/j.ygyno.2015.11.034. Epub 2015 Nov 28.
10
MiR-181a enhances drug sensitivity in mitoxantone-resistant breast cancer cells by targeting breast cancer resistance protein (BCRP/ABCG2).miR-181a 通过靶向乳腺癌耐药蛋白(BCRP/ABCG2)增强米托蒽醌耐药乳腺癌细胞对药物的敏感性。
Breast Cancer Res Treat. 2013 Jun;139(3):717-30. doi: 10.1007/s10549-013-2607-x. Epub 2013 Jun 19.

引用本文的文献

1
Targeting the PI3K Pathway: Advancements and Achievements in Breast Cancer Therapy.靶向PI3K通路:乳腺癌治疗的进展与成果
Curr Pharm Des. 2025;31(31):2481-2503. doi: 10.2174/0113816128357976250122042633.
2
Clinical Relevance and Drug Modulation of PPAR Signaling Pathway in Triple-Negative Breast Cancer: A Comprehensive Analysis.三阴性乳腺癌中PPAR信号通路的临床相关性及药物调控:一项综合分析
PPAR Res. 2024 Dec 21;2024:4164906. doi: 10.1155/ppar/4164906. eCollection 2024.

本文引用的文献

1
The impact of P-glycoprotein and breast cancer resistance protein on the brain pharmacokinetics and pharmacodynamics of a panel of MEK inhibitors.P-糖蛋白和乳腺癌耐药蛋白对一组MEK抑制剂脑药代动力学和药效学的影响。
Int J Cancer. 2018 Jan 15;142(2):381-391. doi: 10.1002/ijc.31052. Epub 2017 Oct 4.
2
1,8-Naphthalimide: A Potent DNA Intercalator and Target for Cancer Therapy.1,8-萘二甲酰亚胺:一种有效的DNA嵌入剂及癌症治疗靶点。
Chem Rec. 2017 Oct;17(10):956-993. doi: 10.1002/tcr.201600134. Epub 2017 Apr 4.
3
PI3K/AKT/mTOR: role in breast cancer progression, drug resistance, and treatment.PI3K/AKT/mTOR:在乳腺癌进展、耐药性和治疗中的作用。
Cancer Metastasis Rev. 2016 Dec;35(4):515-524. doi: 10.1007/s10555-016-9637-x.
4
Novel Therapeutic Strategies Against Cancer: Marine-derived Drugs May Be the Answer?对抗癌症的新型治疗策略:源自海洋的药物会是答案吗?
Anticancer Agents Med Chem. 2016;16(12):1549-1557. doi: 10.2174/1871520616666160211123841.
5
Angiosuppressive properties of marine-derived compounds-a mini review.海洋来源化合物的血管抑制特性——小型综述。
Environ Sci Pollut Res Int. 2017 Apr;24(10):8990-9001. doi: 10.1007/s11356-015-5536-x. Epub 2015 Oct 31.
6
Synthesis and Antiproliferative Activity Evaluation of the Disulfide-Containing Cyclic Peptide Thiochondrilline C and Derivatives.含二硫键的环肽硫海葵毒素C及其衍生物的合成与抗增殖活性评价
J Nat Prod. 2015 Oct 23;78(10):2398-404. doi: 10.1021/acs.jnatprod.5b00428. Epub 2015 Oct 7.
7
A novel Golgi protein (GOLPH2)-regulated oncolytic adenovirus exhibits potent antitumor efficacy in hepatocellular carcinoma.一种新型高尔基体蛋白(GOLPH2)调控的溶瘤腺病毒在肝细胞癌中展现出强大的抗肿瘤功效。
Oncotarget. 2015 May 30;6(15):13564-78. doi: 10.18632/oncotarget.3769.
8
Single-molecule kinetics and footprinting of DNA bis-intercalation: the paradigmatic case of Thiocoraline.DNA双插入的单分子动力学与足迹分析:硫珊瑚菌素的典型案例
Nucleic Acids Res. 2015 Mar 11;43(5):2767-79. doi: 10.1093/nar/gkv087. Epub 2015 Feb 17.
9
The synergistic inhibition of breast cancer proliferation by combined treatment with 4EGI-1 and MK2206.4EGI-1与MK2206联合治疗对乳腺癌增殖的协同抑制作用
Cell Cycle. 2015;14(2):232-42. doi: 10.4161/15384101.2014.977096.
10
Thiocoraline activates the Notch pathway in carcinoids and reduces tumor progression in vivo.硫代珊瑚菌素激活类癌中的Notch信号通路并在体内减少肿瘤进展。
Cancer Gene Ther. 2014 Dec;21(12):518-25. doi: 10.1038/cgt.2014.57. Epub 2014 Nov 21.